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Summary
Circadian clockswere, until recently, seen as a consequence
of rhythmic transcription of clock components, directed by
transcriptional/translational feedback loops (TTFLs). Oscil-
lations of protein modification were then discovered in
cyanobacteria [1, 2]. Canonical posttranslational signaling
processes have known importance for clocks across taxa
[3–11]. More recently, evidence from the unicellular
eukaryote Ostreococcus tauri revealed a transcription-inde-
pendent, rhythmic protein modification [12] shared in
anucleate human cells [13]. In this study, the Ostreococcus
system reveals a central role for targeted protein degrada-
tion in the mechanism of circadian timing. The Ostreococ-
cus clockwork contains a TTFL involving the morning-
expressed CCA1 and evening-expressed TOC1 proteins
[14]. Cellular CCA1 and TOC1 protein content and degrada-
tion rates are analyzed qualitatively and quantitatively using
luciferase reporter fusion proteins. CCA1 protein degrada-
tion rates, measured in high time resolution, feature a sharp
clock-regulated peak under constant conditions. TOC1
degradation peaks in response to darkness. Targeted
protein degradation, unlike transcription and translation, is
shown to be essential to sustain TTFL rhythmicity
throughout the circadian cycle. Although proteasomal
degradation is not necessary for sustained posttranslational
oscillations in transcriptionally inactive cells, TTFL and
posttranslational oscillators are normally coupled, and pro-
teasome function is crucial to sustain both.
Results and Discussion
CCA1 Degradation Is Clock Regulated, and TOC1
Degradation Is Dark Responsive
The Ostreococcus transcription factor CIRCADIAN CLOCK
ASSOCIATED-1 (CCA1) and response regulator TIMING OF
CAB1 EXPRESSION (TOC1) have recently been shown to func-
tion similarly to the Arabidopsis thaliana orthologs, forming
a transcriptional/translational feedback loop (TTFL) thought
to be central to the circadian clock mechanism [14, 15].
Ostreococcus lines expressing CCA1 or TOC1 from their
native promoters as translational fusions to firefly luciferase
were previously characterized [14]. pCCA1::CCA1-LUC and
pTOC::TOC1-LUC lines will be referred to as CCA1-LUC and2These authors contributed equally to this work
3Present address: Department of Astronomy and Theoretical Physics, Lund
University, 223 62 Lund, Sweden
*Correspondence: gerben.vanooijen@ed.ac.uk (G.v.O.), andrew.millar@ed.
ac.uk (A.J.M.)TOC1-LUC. To comprehensively analyze the degradation
rates of CCA1-LUC and TOC1-LUC throughout the circadian
cycle, we blocked de novo protein synthesis using saturating
concentrations [12] of cycloheximide (CHX) at 2 hr intervals
in constant light (LL). Decay rates were calculated from curve
fitting to the initial exponential decay of the CCA1-LUC or
TOC1-LUC trace following treatment (the data and fitted decay
rates are shown in Figures S1A–S1D available online). CCA1
degradation rates showed a peak in the middle of the subjec-
tive day (30 hr into LL, or 6 hr after anticipated dawn; Figure 1A),
roughly coinciding with the trough in CCA1 protein expression
under light:dark (LD) cycles (Figures S1A–S1D). The diurnal
peak was at w0.6 hr21, 2- or 3-fold higher than the trough
rate in the subjective night. This result revealed rhythmic
CCA1 protein degradation in constant conditions.
TheTOC1degradation rate, incontrast, varied little inLL (0.2–
0.27 hr21), prompting us to test its regulation under physiolog-
ically relevant diurnal cycles. Assays in cultures under cycles of
12 hr light:12 hr dark (LD12:12) showed that the TOC1-LUC
degradation rate was higher in darkness (Figure 1A). Because
elementsof LD regulationofTOC1degradationwerepreviously
reported [16, 17],we testedTOC1degradation rates around the
transition to darkness under long (LD18:6) or short (LD6:18)
days. A sharp increase in TOC1 degradation was evident in
long-day conditions but less clear in short-day conditions until
later at night, suggesting that some circadian gating exists on
the increased TOC1 degradation in response to darkness (Fig-
ure 1A). Peak TOC1 decay rates were always higher (up to 2-
fold) indarknesscompared toLL, although thepeak timevaried
depending on day length.
The CCA1-LUC decay rate in LD12:12 peaked from
Zeitgeber Time 6 (ZT6), as in LL, although the peak was signif-
icantly broader (Figure 1A). In LD6:18, the CCA1-LUC degrada-
tion rate again peaked at ZT6 but fell rapidly in darkness to
a low level by ZT12, similar to its profile in LL. We conclude
that the degradation profile of CCA1-LUC is circadian
controlled and additionally shaped by the light:dark cycle,
possibly because of the higher levels of CCA1 observed under
long days compared to short days [18].
Quantitative Analysis of Cellular Clock Protein Content
and Degradation Rate
Decay rates measured as above will reflect the actual protein
degradation plus the deactivation rate of the luciferase
enzyme [19], assuming that these very different processes
are independent. The decay rate for luciferase, dominated by
the deactivation rate [19], was measured by two approaches.
First, cultures containing the transcriptional reporter fusions
pCCA1::LUC and pTOC1::LUC were treated with CHX
(Figure S1E), revealing decay rates slower (between 0.153
and 0.165 hr21) than rates found with the translational fusions.
Second, the rhythmic activity profile of free luciferase in
pTOC1::LUC cultures was monitored in short-day LD cycles,
because TOC1 promoter activity is close to zero in darkness.
Luciferase decay rates over several nights were observed
between 0.136 and 0.143 hr21 (Figure S1F). The observed rates
were close to the value (0.18 hr21) previously estimated by
fitting a mathematical model of the Ostreococcus clock to
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Figure 1. CCA1-LUC and TOC1-LUC Degradation Rates under Different Light Regimes
(A) Degradation rates of CCA1-LUC (blue traces) and TOC1-LUC (red traces) calculated from the curve fitting to the exponential phase of decay following
inhibition of de novo protein synthesis with cycloheximide. The x axis indicates treatment time; light regime is indicated in the panels. Error bars represent
standard error of themean (SEM; n = 5). Decay ratesmeasured for free luciferase ranged from 0.165 to 0.136 hr21, as indicated by the horizontal dotted lines.
(B) Number of CCA1-LUC (blue line) or TOC1-LUC (red line) molecules/cell for an LD12:12 cycle calculated by in vitro luciferase activity of cell extracts (mean
values plotted 6 SEM; n = 2).
(C) Absolute degradation rates in molecules/cell/hr for CCA1-LUC (blue lines) and TOC1-LUC (red lines) obtained frommultiplying decay rates by molecule
number (mean values plotted 6 SEM; n = 2). See also Figure S1.
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870a large set of luciferase data [18]. In conclusion, deactivation of
luciferase constitutes only a minor fraction of the peak rate of
rhythmic CCA1 degradation but a substantial fraction of the
lowest rate, as indicated by the horizontal dotted lines in
Figure 1A.
Using an in vitro luciferase activity assay, the number of
CCA1-LUC or TOC1-LUC molecules per cell was estimated
under LD12:12 by comparing the activity of cell extracts from
a known number of cells to a recombinant luciferase standard
of known activity. CCA1-LUC cycled between peak and trough
levels of close to 400 and 80 molecules/cell, and TOC1-LUCcycled between 150 and 10 molecules/cell (Figure 1B). Subse-
quently, multiplying decay rates (hr21) with molecule counts
(molecules/cell) would allow an estimation of absolute degra-
dation at any time in molecules/cell/hr. To negate the effect of
luciferase deactivation, we subtracted the average rate value
(0.15 hr21) from the decay rates. Absolute CCA1-LUC degra-
dation (Figure 1C) peaked around ZT8, relating to w75
molecules/cell/hr. Higher degradation rates of CCA1 thus
contributed to reaching the trough level of CCA1 protein
around ZT9 (Figure S1B). The increased level of TOC1-LUC
decay in darkness related tow40 molecules/hr.
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Figure 2. Effects of Proteasomal Inhibition
(A) Period difference relative to vehicle-treated cells, resulting from treatment with indicated concentrations of epoxomicin or PYR-41 on CCA1-LUC
(red bars) or pCCA1::LUC (black bars). Error bars represent standard deviation (SD; n = 8).
(B) Effect of epoxomicin (blue traces, n = 4) or MG132 (red traces, n = 8) on CCA1-LUC in downward (top) or upward (bottom) phase, compared to vehicle
(black traces, n = 8). See also Figure S2.
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871The low molecule numbers in the crowded cellular environ-
ment could indicate that stochastic effects might not be trivial
in the Ostreococcus clock. Comparisons between determin-
istic and stochastic models of the Ostreococcus clock using
a range of molecule numbers, including the levels experimen-
tally observed here, have previously revealed that stochastic-
ity indeed has potentially significant effects on free-running
behavior and desynchronization of cells [20].
These results, utilizing the unique advantagesOstreococcus
tauri offers, expand previous knowledge fromArabidopsis and
lead to the first estimates of clock component molecule
number per cell in any plant or algal model organism, as well
as, to our knowledge, the most detailed in vivo analysis of
rhythmic clock component degradation rates.Ostreococcus Shares Components of Arabidopsis
Clock Protein Degradation Pathways
Arabidopsis CCA1 homolog LATE ELONGATED HYPOCOTYL
(LHY) is rapidly degraded in vitro by the proteasome in plant
extracts [21] in a process negatively regulated by DE-
ETIOLATED1 (DET1). DET1 has also been shown to regulate
the degradation of transcription factors involved in light
signaling, together with ubiquitin ligase CONSTITUTIVE
PHOTOMORPHOGENIC 1 (COP1) [22]. The Ostreococcus
genome encodes an ortholog of the Arabidopsis DET1 and
COP1 proteins (CAL55339 and CAL53135, respectively).
Arabidopsis TOC1 is targeted for degradation via the F-box
protein ZEITLUPE (ZTL) in a dark-dependent fashion [16].
Because the Ostreococcus genome contains a homolog of
ZTL (CAL53380), this protein might contribute to TOC1degradation, although the algal protein lacks the chromo-
phore-binding LOV domain of ZTL. Other factors that regulate
TOC1 stability in Arabidopsis (PRR3 [23], FKF1 and LKP2 [24],
and GI [25]) are not conserved.
Ostreococcus DET1, COP1, and ZTL were recently found to
be differentially expressed under LD12:12 cycles. ZTL peaked
in the night, and DET1 peaked during the day (Figure S1G,
adapted from [26]), consistent with roles in degrading TOC1
at night (ZTL) or stabilizing CCA1 during the day (DET1).
Further studies will be necessary to fully establish the contri-
butions of protagonists and antagonists of clock component
protein stability and their mechanisms of light dependence.Effects of Pharmacological Inhibition of Targeted Protein
Degradation on Free-Running Behavior
The widely used proteasome inhibitor MG132 increases the
free-running period in a dose-dependent fashion inOstreococ-
cus [12]. MG132 is a trileucine aldehyde, inhibiting proteasome
subunits b1 and b5, but it also targets papain-like cysteine
proteases in plants [27]. To verify that modulating the protea-
some pathway indeed affects the Ostreococcus free-running
period, we analyzed the effects of the highly selective protea-
some inhibitor epoxomicin [28],which inhibits all three catalytic
proteasome subunits in plants [27]. Low micromolar concen-
trations of this drug resulted in robust period increases of
w9–10 hr (Figure 2A and Figure S2A). Furthermore, an inhibitor
(PYR-41) [29] that acts on the ubiquitin/proteasome pathway
via inhibition of ubiquitin-activating enzymes yielded similar,
albeit less potent, effects in the lengthening period (Figure 2A
and Figure S2B). In combination, the effects of these inhibitors









32 Hypothesis 1: Stop ticking







Duration of inhibition (hrs)






Time in  LL (h)



















Figure 3. Proteasomal Inhibition Stops TTFL Rhythmicity Phase-Independently
(A) Application of saturating concentrations of MG132 (40 mM, red traces) or vehicle (black traces) to CCA1-LUC cells in constant light.
(B) Examples from wedge data of peak phases of individual wells (n R 6) of CCA1-LUC cells subjected to various (0–24) hours of proteasomal inhibition
(red wedge, right) or vehicle (gray wedge, left) starting at ZT0 and ending by wash off.
(C) Summary of phase shifts (error bars represent SD, nR 6) relative to vehicle-treated controls for all treatment durations (x axis) and starting times. Two
black lines represent the expected result, assuming either total resetting by wash off (hypothesis 1) or no effect (hypothesis 2). See also Figure S3.
Current Biology Vol 21 No 10
872show that targeted protein degradation via the proteasome is
indeed necessary to maintain rhythmicity.
However, when proteasomal inhibitors were applied to
CCA1-LUCOstreococcus cells before the peak in CCA1 degra-
dation rate (Figure 1A), no immediate effect was observed on
CCA1-LUC traces (Figure 2B, top), and theCCA1 level dropped
to trough levels, as in vehicle-treated cells. However, rhyth-
micity was not sustained because CCA1 levels did not rise at
the appropriate phase, possibly meaning that increased
CCA1 protein degradation toward trough levels is not directly
proteasome mediated, but proteasomal activity is necessary
to allow CCA1 levels to rise from trough levels. We consider
the most parsimonious explanation to be that proteasomal
degradation of a negative regulator is associated with rising
CCA1 levels. In linewith this hypothesis,whenproteasome inhi-
bition was applied at a phase when CCA1-LUC levels were
rising (Figure 2B, bottom), the upward trend was curtailed.
Several transcriptional repressors of CCA1 have been iden-
tified in the Arabidopsis clock, including members of the
pseudo-response regulator (PRR) family [30] to which TOC1
belongs, or the TCP transcription factor CCA1 HIKING EXPE-
DITION (CHE) [31]. Ostreococcus does not contain any TCP
transcription factors, and TOC1 is a single gene that is thought
to function as an activator of algalCCA1 rather than a repressor
[18]. It is possible that our results will not be explained by tran-
scriptional control but rather bymodulation of negative regula-
tors such as DET1 and COP1 acting on the CCA1 protein itself,
as DET1 does on Arabidopsis LHY [21].
Proteasome Inhibition Arrests the Clock Regardless
of Phase
Until recently, circadian rhythms were regarded to be dictated
by rhythmic expression of core clock proteins: in green cells,
mainly LHY/CCA1 and TOC1 [32]. This dogma was challengedin cyanobacteria by the notion that the three clock proteins
KaiA, KaiB, and KaiC generated an w24 hr rhythmic output
in vitro [1, 2], but such biochemical oscillations were not iden-
tified in eukaryotes. Underexposed intellectual precedent
exists that questions this TTFL model, showing that at least
in certain taxa, transcription is not essential for rhythmicity. It
was shown that the nucleus was not necessary for rhythmicity
in Acetabularia [33, 34] and that translational rather than
transcriptional control is critical to rhythmicity in Lingulodinium
(previously known as Gonyaulax) [35]. Furthermore, clock
networks generally keep oscillating even if core TTFL compo-
nents are misexpressed [36]. Recent work on Ostreococcus
has shown that substantial parts of the circadian cycle are
insensitive to inhibition of transcription or translation, in
contrast to the behavior expected if the TTFL was the only
driver of rhythmicity [18], and that posttranslational oscilla-
tions persist after several days without TTFL rhythmicity [12].
The observation that degradation rates and molecule
numbers of clock proteins are never at 0 (Figure 1) suggested
that targeted degradation might set their levels at all phases.
An implication would be that proteasome inhibition would
potentially alter circadian timing at any phase. The reversible
characteristics of proteasome inhibitor MG132 allowed the
testing of this hypothesis using pulsed treatments, ended by
wash off.
Saturating concentrations of MG132 arrested rhythmic
behavior of the CCA1-LUC line (Figure 3A). CCA1-LUC cells
entrained in LD12:12 cycles were transferred to constant light
at dawn (ZT0), and application of MG132 stopped normal
oscillatory behavior. After wash off, the cells directly resumed
oscillations (Figure S3A), suggesting that treatment was
reversible and largely nontoxic. The delay in phase resulting
from treatment pulses followed a direct relation with the dura-
tion of the treatment (Figure S3B), suggesting that the
AB
Figure 4. Application of MG132 Arrests Cytosolic Oscillations
(A) Three independent 48 hr time series of protein extracts in constant light with vehicle or MG132 treatment starting after 12 hr. Samples were run on immu-
noblots using a PRX-SO2/3 antibody. For equal loading control, Coomassie staining of Rubisco (RbcL) is shown on a representative gel (bottom panels).
(B) Densitometry performed with ImageJ64 showing grouped data of the three replicates for vehicle-treated (black line) or MG132-treated (blue line) cells.
Dotted lines indicate SD; blue shaded area indicates window of inhibition. See also Figure S4.
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873circadian pacemaker had paused. The period of the reinitiated
rhythm after wash off was not substantially affected (Fig-
ure S3C), showing that wash off was efficient and that drug
concentration was reduced to insignificant levels. The ability
of treated cells to re-entrain was demonstrated by reinstating
LD12:12 cycles after 48 hr of constant light (Figure S3A).
Altogether, this indicates that when drugs are applied at ZT0,
the Ostreococus clock is paused by MG132, and cells reset
to wash off.
Warranted by the results described above, we exploited
pulsed inhibition to comprehensively test sensitivity to protea-
somal inhibition throughout a 24 hr cycle. LD12:12-entrained
CCA1-LUC cells were subjected to pulses of increasing
duration (4, 8, 12, 16, 20, and 24 hr), starting at 4 hr intervals
throughout the circadian cycle in constant light. Phase
information after wash off was recorded to analyze whether
phase systematically departed from vehicle-treated cells.
This type of experiment is referred to as a ‘‘wedge’’ experiment
[37, 38], named after the anticipated shape of phase outputs,
assuming that treatment stops the clock altogether and that
cells reset to wash off. If inhibition of a drug target would not
affect the clock, the resulting phase should be similar to
vehicle-treated cells (Figure 3C). In Ostreococcus, inhibition
of transcription or translation leads to complex, phase-depen-
dent responses following neither of the two hypotheses [12]. In
contrast, pulses of MG132 resulted in exactly the anticipated
wedge shape predicted by full resetting towash off, regardless
of what time treatment is started (Figures 3B and 3C andFigure S3G). This result shows that, in contrast to transcription
and translation [12], proteasome function determines time-
keeping at all phases.
Rhythmic Sulphonylation of Peroxiredoxin Proteins
Is Arrested by Proteasomal Inhibition
Peroxiredoxins are an evolutionarily conserved group of anti-
oxidant enzymes. Scavenging reactive oxygen species drives
hyperoxidation of a redox-active cysteine to sulphonic acid
(sulphonylation), which in turn drives formation of homo-oligo-
mers [39, 40]. Circadian sulphonylation of peroxiredoxin
proteins (PRX) was observed in transcriptionally incompetent
Ostreococcus cells [12], as well as in mature (naturally
anucleate) human red blood cells [13], indicating that TTFLs
alone cannot explain all circadian outputs. Unlike most basic
physiological processes in this photosynthetic organism [26,
41], rhythmic peroxiredoxinmodification persisted in darkness
[12]. Blocking transcription, translation, or light fails to stop
this rhythm, so we investigated whether inhibition of targeted
protein degradation would do so in conditions in which the
other three factors were uncompromised. LD12:12-entrained
cells were transferred to constant light, and rhythmic PRX
sulphonylation was analyzed on western blots using an anti-
body specifically targeting the sulphonylated PRX-SO2/3
forms. Vehicle-treated cells showed strong rhythms in PRX
modification in LL (Figure 4). When MG132 was applied 12 hr
into constant light, PRX-SO2/3 rhythmicity was paused or
dramatically slowed (Figure 4). Thus, proteasome function is
Current Biology Vol 21 No 10
874necessary for posttranslational rhythmicity in cells that are
competent to synthesize new proteins. This result indicates
that the nontranscriptional oscillator is strongly coupled to
the TTFL, such that an arrhythmic TTFL can stop or severely
perturb the nontranscriptional rhythm.
We next explored the effect of proteasome inhibition on the
nontranscriptional oscillator in cells that were incompetent for
de novo TTFL component synthesis, i.e., Ostreococcus cells
in constant darkness. Pharmacological treatments acting on
posttranslational modulators had similar effects on the period
of PRX rhythmicity in these cells as they did on TTFL rhythms
in cells under constant light [12], showing that multiple
biochemical processes are involved in generating the nontran-
scriptional rhythm. We hypothesized that proteasome function
would not be among them (so MG132 would not affect PRX
rhythms in constant darkness), because if posttranslational
rhythms relied on targeted protein degradation, they could not
persist over several days without de novo synthesis. Indeed,
rhythmic sulphonylation of PRX was still observed with satu-
rating concentrations of MG132 in darkness (Figure S4).
These results indicate, more clearly than experiments using
transgenic lines with altered period length [12], that the TTFL
and posttranslational oscillators are strongly coupled under
physiologically relevant conditions and that proteasome func-
tion is crucial to sustain their joint operation. However, post-
translational oscillations are uncoupled from proteasomal
degradation in darkness, when the TTFL appears to be absent
rather than inhibited. It is unclear which of many cellular
changes between light-grown and darkened algal cells allow
this uncoupling of the posttranslational oscillator. Similar
behavior was observed in mammalian cells [13], comparing
anucleate red blood cells (TTFL absent, PRX rhythmic) and
cry1cry2 mutant fibroblasts (TTFL inhibited, PRX arrhythmic
or aberrant).
Shutdown of cellular transcription/translation and an
apparent independence from proteasomal degradation might
reflect a survival mechanism for Ostreococcus cells in nature
when oceanic currents carry them to places where light levels
are insufficient to provide energy for functions such as cell
division and protein synthesis. The fact that cells in this
near-dormant state are still oscillating suggests that rhyth-
micity should be seen as a fundamental property of living cells
that exists even in cells that gain no apparent benefit from
anticipating the solar cycle, like human red blood cells [13].
Based on recent identification of posttranslational compo-
nents in clocks across taxa [1, 2, 4, 12, 13, 42], this work
explores the contributions of rhythmic proteolysis in eukary-
otic cellular timekeeping. A free-running peak in CCA1
degradation rate is reported, whereas TOC1 degradation is
accelerated in darkness. Furthermore, proteasomal degrada-
tion of a negative regulator might be involved in CCA1
synthesis. Proteasomal inhibition is shown to stop transcrip-
tional clock output at any phase. Taking into account that
transcription/translation is not required throughout the full
circadian cycle to sustain rhythmicity in Ostreococcus, this
study establishes the position of rhythmic targeted protein
degradation as not only a central element but also a constant
requirement for timekeeping, at least in this organism.Experimental Procedures
Culturing
Materials were ordered from Sigma-Aldrich (UK) unless indicated. Ostreo-
coccus tauri cells were grown under 12:12 hr blue (Ocean Blue, Lee lightingfilter 724) LD cycles (17.5 mE/m2) in artificial sea water (Instant Ocean) sup-
plemented with Keller marine enrichment nutrients, hereafter referred to as
ASW.
Imaging
Bioluminescent imagingwas performed on a TopCount (Packard) fitted with
red and blue LED lights (5–12 mE/m2 depending on position in plates) in
white 96-well plates (Lumitrac, Greiner Bio-one). Five to seven days before
recording, cells were plated at a density of 5–10 3 106 cells/ml and kept
under entrainment conditions. One day before imaging, 150 ml ASW was re-
placed with 150 ml ASW containing 333 mM luciferin. Period and phase anal-
yses were carried out using the fast Fourier transform (FFT)-nonlinear least
squares or mFourfit functions, respectively, in BRASS 3 software [43],
based on data spanning at least three circadian cycles (with the exception
of period and phase estimates in Figures S3B, S3C, S3E, and S3F, where
just two cycles of LL data were used). Outputs were manually confirmed.
Pharmacology
Drugs were dissolved in dimethyl sulfoxide, diluted in ASW, and added to
the saturated or otherwise indicated concentrations. Saturating concentra-
tions are: CHX, 1 mg/ml; MG132, 40 mM; epoxomicin, 10 mM. For data in Fig-
ure 1 and Figures S1A–S1D, n = 5, vehicle control n = 3. For Figure 2B, n = 8
for MG132 and n = 4 for epoxomicin. For Figure 2A, Figure 3, and Figure S3,
treatment and vehicle controls are n = 8.
Calculating Degradation Rates
Luminescence measurements in the exponential decay phase following
CHX treatment (0.5 to 3.7 hr after treatment) were used to calculate degra-
dation rates, as detailed in the legend to Figure S1.
Luciferase Assays
Analysis of CCA1 and TOC1 molecule counts (Figure 1B) was performed by
comparing luciferase activity in cell extracts prepared from a known number
of cells (as analyzed in a haemocytometer) in 5 ml culture with a commercial
luciferase standard of known concentration in the Luciferase Reporter Gene
Detection Kit (Sigma-Aldrich, LUC-1).
Wedge Experiment
Wedge experiments were performed as detailed in [12] and in the legend to
Figure S3.
Western Blotting
Western blot analyses of PRX modification were performed as described in
[12] and in the legend to Figure S4. Densitometry was performed using Im-
ageJ64 (W. Rasband, National Institute of Mental Health).
Supplemental Information
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.cub.2011.03.060.
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Figure S1. Data Used for Calculating Clock Protein Decay Rates, Related to Figure 1 
(A-D) Luminescent traces on a log scale, from all experimentation used to compute 
degradation rates plotted in Figure 1A. De novo protein synthesis was inhibited with CHX 
(CCA1-LUC; blue lines, TOC1-LUC; red lines, n=5) compared to vehicle (black lines, n=3). 
This experiment was performed on the second day of constant light (A), or in LD12:12 (B), 
LD6:18 (C), or LD18:6 (D). Straight lines on this logarithmic scale represent fits to the data, 
and the decay rate d (h-1) is indicated. Dotted lines indicate treatment time. For each pair of 
consecutive time points, the decay rates of the five replicate wells were computed, and 
reduced to their mean and standard deviation. Subsequently, the mean of the estimated 
decay rates was computed across the pairs of consecutive time points, weighted by the 
reciprocal of the standard deviation. This procedure was found to be more robust than 
alternative methods.  
(E) The luciferase deactivation rate was estimated by linear regression of the exponential 
signal decay of luciferase expressed from the CCA1 (pCCA1::LUC) or TOC1 (pTOC1::LUC) 
promoter, following treatment with CHX (n = 4, SD = 0.005 h-1 for both lines).  
(F) As an independent means, luciferase decay was measured over several nights using 
pTOC1::LUC in short day conditions (n = 8, SD ≤ 0.003 h-1, using ZT 14-24 of each day).  
(G) Rhythmic transcription in Ostreococcus cells in LD12:12 cycles of proteins involved in 





Figure S2. Representative Free-Running Traces in Response to Pharmacological 
Inhibition, Related to Figure 2 
Traces of CCA1-LUC (top panels) and pCCA1-LUC (lower panels) resulting from inhibition 
with indicated concentrations of inhibitors against the proteasome (epoxomicin, A) or 
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Figure S3. Full Results of Pulsed Treatments with Proteasome Inhibition, Related to 
Figure 3 
For wash-off of MG132 (A-D), all ASW was pipetted from the cell aggregates that naturally 
form in the bottom of microplate wells, and quickly but gently washed with fresh ASW plus 
luciferin, using an 8-channel pipette. The effects of epoxomicin were found to be 
irreversible ([27] and data not shown). However, the highly comparable qualitative and 
quantitative effects of MG132 and epoxomicin (Figure 2) strongly indicated that inhibitory 
effects on the proteasome at least strongly dominate the effects observed using MG132.  
(A) Traces from CCA1-LUC lines entrained in 12:12 LD cycles and released into LL for 2 
days at ZT0, with MG132 (red traces) or vehicle treatment (black traces) starting at 
transfer to LL and for increasing duration. Wash-off is indicated by black dotted lines. 
Phase ( ) change (± SD, n=8) resulting from treatment relative to vehicle treatment is 
indicated. After 2 days, a 12:12 light/dark regime was reinstated to check for the cells’ 
ability to re-entrain to a photoperiod (indicated with black shades). 
(B-C) Effects of treatment depicted in A) on phase (B) and period (C) of subsequent CCA1-
LUC oscillations.  
(D) Full results of wedge experiment with proteasome inhibition. Peak times of individual 
replicates of CCA1-LUC expression in constant light after entrainment in 12:12 LD cycles 
and treatment with vehicle (left hand graphs, black wedges) or MG132 (right hand graphs, 
red wedges) starting from ZT0, 4, 8, 12, 16, or 20 extending for 4-hour increments up to 24 





Figure S4. Application of MG132 Does Not Arrest Cytosolic Oscillations in 
Transcriptionally Inactive Cells, Related to Figure 4 
Three independent 48-hour time series of protein extracts starting 12 hours into DD (ZT0), 
with vehicle or MG132 applied 24 hours into DD (ZT12). For equal loading control, 
coomassie staining of Rubisco (RbcL) is shown on a representative gel (lower panels). 5 ml 
of cells were quickly chilled on ice and centrifuged for 10 minutes at 4 C at 4,000 g, 
supernatant was discarded and cells were resuspended in 50 µl ASW, lysed by addition of 
50 µl 2x extraction buffer (from LUC-1 detection kit), and mixed with 100 µl 2x Laemmli 
sample buffer before loading on a 4-12% NuPage Novex Bis-Tris midi gel (Invitrogen). For 
sampling in constant darkness, ASW was supplemented with 200 mM sorbitol and 0.4% 
glycerol.  
 
Gels were blotted using an iBlot system (Invitrogen) and following transfer, RbcL protein 
remaining in the gel was stained as a loading control using SimplyBlue SafeStain 
(Invitrogen). Immunostaining was performed using a rabbit polyclonal Peroxiredoxin-SO2/3 
antibody (Abcam ab16830) combined with HRP-labelled secondary antibodies (Abcam 
ab6721). 
